miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer
Abstract Background The tumor suppressive role of miR-1296 is observed in triple negative breast cancer (TNBC). However, the effect of miR-1296-5p in ERBB2-positive breast cancers remains obscure. Methods Whether ERBB2 was the target gene of the miR-1296-5p was predicted by online software, and dete...
Main Authors: | Gang Chen, Mingfeng He, Yin Yin, Ting Yan, Wenfang Cheng, Zebo Huang, Lan Zhang, Huo Zhang, Ping Liu, Wei Zhu, Yichao Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-017-0466-y |
Similar Items
-
Treatment of ErbB2 breast cancer by mitochondrial targeting
by: Sophia Eldad, et al.
Published: (2020-07-01) -
Improved delivery of miR-1296 loaded cationic nanoliposomes for effective suppression of triple negative breast cancer
by: Lamyaa Albakr, et al.
Published: (2021-05-01) -
Circ_0000520 contributes to triple‐negative breast cancer progression through mediating the miR‐1296/ZFX axis
by: Yong Zhou, et al.
Published: (2021-09-01) -
miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
by: Xia Shan, et al.
Published: (2017-01-01) -
Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas
by: Ilianna Zoi, et al.
Published: (2019-12-01)